comprehensive -WSS

comprehensive

author：knowledge 2025-09-30 17:45:33 - browse：397

Two people in protective equipment work in a lab. — JUAN MABROMATA/AFP via Getty Images

Biosimilars are no longer a new and untested class of medicines. Today, they provide critical treatment options across multiple therapeutic areas. Since the Biologics Price Competition and Innovation Act of 2009 created a regulatory pathway for biosimilar medicine review in the U.S., 37 biosimilars have come to market offering the potential to increase patient choice and cost savings. And according to the 2023 analysis from IQVIA, biosimilars are expected to generate $181 billion in savings for the U.S. health care system over the next five years.

This progress is due, in part, to thoughtfully considered, scientifically robust regulatory standards, which have instilled confidence among health care providers and patients while protecting safety. As a former associate director of therapeutic biologics at the Food and Drug Administration, I had the privilege of helping create and lead implementation of the regulatory framework for biosimilars. The FDA took great care to apply appropriate scientific rigor to the development and approval standards. While I have since moved to Amgen, my goals have remained focused on biosimilar product quality and efficacy, patient safety, and prescriber confidence.

More than a decade later, collective efforts by biosimilar manufacturers and the FDA are paying off.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： New research casts further doubt on a common procedure used with IVF

WSS

Oak trusses raised to roof of fire

What to know about OceanGate, the company behind the missing Titanic submersible

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Why 40% Americans with Parkinson’s don’t see a neurologist

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Living with Fabry disease, a condition that causes chronic pain

entertainment

comprehensive

Wikipedia

Affirmative action in medical school literally saved lives

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Moonlake's readout produced a cash windfall. Risks remain

Beach reads and more: STAT's 2023 summer book list

Psychedelics group wrestles with new pharma identity

New research casts further doubt on a common procedure used with IVF

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

UnitedHealth argues against case alleging wrongful AI care denials

Jerome Adams on the need for new antivirals for Covid

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Wikipedia

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Questions and answers about ramping up H5N1 bird flu vaccine

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Making the case for fair compensation in clinical trials

Fentanyl is making it harder to start addiction treatment

Cue Health, Covid

leisure time

focus

focus

hotspot